Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-04-04 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document text is extremely short (619 characters) and contains only a headline and a clear instruction/link to 'Read the full announcement in PDF' with an attachment link. This structure strongly indicates an announcement about the publication of a report or news item, rather than the report itself. Since the content relates to a strategic business update (partnership continuation), it is not a standard regulatory filing like 10-K or ER. Given the nature of announcing a specific update/news item, and the short length adhering to the 'MENU VS MEAL' rule, the most appropriate classification is Report Publication Announcement (RPA) or Regulatory Filing (RNS). RPA is chosen because it explicitly announces the publication of information/a document.
2019-04-04 English
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is a formal announcement dated April 4, 2019, titled "Novozymes og BioAg: Fortsættelse med Bayer som nøglepartner; ny bredere struktur åbner op for, at Novozymes kan bringe biologiske løsninger til markedet med flere partnere". It details strategic changes in the BioAg business, including the dissolution of 'The BioAg Alliance' and the establishment of new partnerships (Univar Solutions, UPL). Crucially, it updates financial guidance for 2019, including organic sales growth, operating margin, earnings growth, and free cash flow, presented in a comparative table. This structure—announcing strategic news alongside specific updates to financial outlooks for the current year—is characteristic of an Earnings Release (ER) or a major corporate announcement that precedes a full report. Since it provides key financial highlights and guidance updates immediately, it fits the definition of an Earnings Release (ER) better than a general Regulatory Filing (RNS) or a comprehensive Interim Report (IR), which would typically contain full financial statements. It is not a full Annual Report (10-K) or a Quarterly Report (IR) as it focuses on strategic shifts and guidance revisions rather than detailed period-end financials.
2019-04-04 Danish
Summary of capital reduction pursuant to Article 32 of the Danish Capital
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding a reduction in share capital (kapitalnedsættelse) and the subsequent update to the total share capital and voting rights, as required by the Danish Capital Markets Act. This falls under the category of share capital changes and corporate structure updates, which is best classified as SHA (Share Issue/Capital Change).
2019-03-29 Danish
Summary of capital reduction pursuant to Article 32 of the Danish Capital
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (427 characters) regarding a capital reduction ('kapitalnedsættelse'). It explicitly directs the reader to a link for the full announcement and provides an attached file. According to the 'Menu vs Meal' rule, since this is a short announcement about the publication of a document rather than the full report itself, it is classified as a Report Publication Announcement.
2019-03-29 English
Summary of capital reduction pursuant to Article 32 of the Danish Capital
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding a reduction in share capital and the subsequent update to the company's total capital stock and voting rights, as required by the Danish Capital Markets Act. This falls under the category of share capital changes and capital structure updates.
2019-03-29 English
Summary of capital reduction pursuant to Article 32 of the Danish Capital
Capital/Financing Update Classification · 95% confidence The document is very short (440 characters), serves as a brief notification regarding a capital reduction, and explicitly directs the reader to an external link to read the 'full announcement' or 'attachment'. This fits the 'Menu vs Meal' rule for a Report Publication Announcement (RPA).
2019-03-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.